Evidence map›Paper›PMID 36582722›Full record

ArticleHeliyon2022

Antimicrobial use and its association with the presence of methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing coliforms in mastitic milk on dairy farms in the Chiba Prefecture, Japan.

Masato Kikuchi, Takuma Okabe, Hideshige Shimizu, Takashi Matsui, Fuko Matsuda, Takeshi Haga, Kyoko Fujimoto, Yuko Endo, Katsuaki Sugiura

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Extended-Spectrum Beta-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2024
    Review
  4. Antimicrobial Resistance Profiles ofAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Masato KikuchiChiba Prefectural Agricultural Mutual Aid Association, Chiba, Japan.
Takuma OkabeChiba Prefectural Agricultural Mutual Aid Association, Chiba, Japan.
Hideshige ShimizuChiba Prefectural Agricultural Mutual Aid Association, Chiba, Japan.
Takashi MatsuiChiba Prefectural Agricultural Mutual Aid Association, Chiba, Japan.
Fuko MatsudaDepartment of Veterinary Medical Sciences, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
Takeshi HagaDepartment of Veterinary Medical Sciences, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
Kyoko FujimotoLaboratory of Environmental Sciences for Sustainable Development, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
Yuko EndoLaboratory of Environmental Sciences for Sustainable Development, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
Katsuaki SugiuraLaboratory of Environmental Sciences for Sustainable Development, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPNippon Institute for Biological Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Food-producing animals, including dairy cattle, are potential reservoirs of antimicrobial resistance. However, there is limited data on antimicrobial use and the selection of resistant bacteria. Therefore, we investigated the association between antimicrobial use and resistance to mastitis pathogens using 2016 data from milk samples collected from cows with mastitis in 134 dairy farms in Chiba Prefecture, one of the principal dairy production prefectures in Japan. We recorded the antimicrobial use and isolation of methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamase (ESBL)-producing coliforms (

Indexed as

Antimicrobial resistance (AMR)Antimicrobial treatment incidence (ATI)Antimicrobial useDairy cattleDefined daily dose (DDD)Extended-spectrum beta-lactamase (ESBL)-Producing coliformsJapanMastitisMethicillin-resistant staphylococci (MRS)

Identifiers

PMID36582722
PMCPMC9793267
OpenAlexW4311771198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.